The Neutropenic Diet: An Examination of the Risks and Benefits.

This article examines the neutropenic diet, a restrictive, low-microbial diet often prescribed to patients with severe neutropenia—defined as an absolute neutrophil count below 500 per microliter—commonly seen in cancer patients undergoing chemotherapy. The diet aims to reduce infection risk by avoiding raw or potentially contaminated foods, but its efficacy remains unclear due to a lack of standardized definitions and limited evidence supporting infection prevention benefits. Research indicates that restrictive diets like the neutropenic diet may contribute to malnutrition, weight loss, nausea, and decreased quality of life, which are significant concerns given the high prevalence of malnutrition in cancer patients and its impact on morbidity and mortality. Current guidelines from major organizations vary, with many recommending safe food-handling practices rather than strict dietary restrictions, and oncology nurses play a key role in balancing infection prevention with nutritional support and patient education. Further research is needed to clarify the risks and benefits of the neutropenic diet and to develop evidence-based nutritional guidelines for neutropenic patients.